As Bristol Myers Squibb rolls ahead with its plan to cut $1.5 billion in costs by the end of the year, the drugmaker is once ...
Shares of Bristol Myers Squibb Co. BMY rose 1.39% to $59.62 Friday, on what proved to be an all-around positive trading ...
Quintet Private Bank Europe S.A. reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 8.8% in ...
The brain drug developer is continuing a trial despite a recommendation it be stopped for futility. Elsewhere, Eli Lilly ...
Ongoing strategic partnership advances joint pipeline in neurodegeneration researchEvotec receives a $20 million payment to further progress research HAMBURG, DE / ACCESS Newswire / March 4, 2025 / Ev ...
It was a big month for retirements, with AMC Entertainment and Bristol Myers Squibb both announcing planned exits for ...
Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental biologics ...
In other words, for those looking for "forever stocks," it's not a bad idea to look in this sector. And even with a modest ...